Live Breaking News & Updates on Thoracic Society International Conference

Stay updated with breaking news from Thoracic society international conference. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Dupilumab shows promising results in Phase 3 trial for COPD with type 2 inflammation

Chronic obstructive pulmonary disease patients with type 2 inflammation may soon gain access to a new drug -; dupilumab -; that showed rapid and sustained improvements in patients in a pivotal Phase 3 clinical trial, researchers report in the New England Journal of Medicine. ....

San Diego , United States , Lungenclinic Grosshansdorf , Surya Bhatt , Klaus Rabe , University Of Alabama At Birmingham , Regeneron Pharmaceuticals Inc , American Thoracic Society International Conference , New England Journal , United States Food , Drug Administration , Birmingham Department , Medicine Division , Critical Care , Regeneron Pharmaceuticals , Thoracic Society International Conference ,